These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis. Keesen TS; Antonelli LR; Faria DR; Guimarães LH; Bacellar O; Carvalho EM; Dutra WO; Gollob KJ Clin Exp Immunol; 2011 Sep; 165(3):338-51. PubMed ID: 21726211 [TBL] [Abstract][Full Text] [Related]
9. The F1F3 Recombinant Chimera of Alves-Silva MV; Nico D; de Luca PM; Palatnik de-Sousa CB Front Immunol; 2019; 10():724. PubMed ID: 31024556 [No Abstract] [Full Text] [Related]
10. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles. Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546 [TBL] [Abstract][Full Text] [Related]
11. Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure. Brelaz-de-Castro MC; de Almeida AF; de Oliveira AP; de Assis-Souza M; da Rocha LF; Pereira VR Cell Immunol; 2012 Oct; 279(2):180-6. PubMed ID: 23246680 [TBL] [Abstract][Full Text] [Related]
12. CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis. Santos Cda S; Boaventura V; Ribeiro Cardoso C; Tavares N; Lordelo MJ; Noronha A; Costa J; Borges VM; de Oliveira CI; Van Weyenbergh J; Barral A; Barral-Netto M; Brodskyn CI J Invest Dermatol; 2013 Jun; 133(6):1533-40. PubMed ID: 23321919 [TBL] [Abstract][Full Text] [Related]
13. Leishmania braziliensis-reactive T cells are down-regulated in long-term cured cutaneous Leishmaniasis, but the renewal capacity of T effector memory compartments is preserved. Pereira-Carvalho R; Mendes-Aguiar CO; Oliveira-Neto MP; Covas CJ; Bertho AL; Da-Cruz AM; Gomes-Silva A PLoS One; 2013; 8(11):e81529. PubMed ID: 24303052 [TBL] [Abstract][Full Text] [Related]
15. Antigenic fractions of Leishmania (Viannia) braziliensis: the immune response characterization of patients at the initial phase of disease. Brelaz MC; de Oliveira AP; de Almeida AF; de Assis Souza M; Medeiros ÂC; de Brito ME; Pereira VR Parasite Immunol; 2012 Apr; 34(4):236-9. PubMed ID: 22394223 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic and Functional Profiles of Antigen-Specific CD4 Egui A; Ledesma D; Pérez-Antón E; Montoya A; Gómez I; Robledo SM; Infante JJ; Vélez ID; López MC; Thomas MC Front Cell Infect Microbiol; 2018; 8():393. PubMed ID: 30510917 [TBL] [Abstract][Full Text] [Related]
17. Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection. Cardoso TM; Machado Á; Costa DL; Carvalho LP; Queiroz A; Machado P; Scott P; Carvalho EM; Bacellar O Infect Immun; 2015 Mar; 83(3):898-906. PubMed ID: 25534940 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of Potential CD4 E Silva RF; de Oliveira BC; da Silva AA; Brelaz de Castro MCA; Ferreira LFGR; Hernandes MZ; de Brito MEF; de-Melo-Neto OP; Rezende AM; Pereira VRA Front Immunol; 2019; 10():3145. PubMed ID: 32117204 [No Abstract] [Full Text] [Related]
19. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? Gomes-Silva A; de Cássia Bittar R; Dos Santos Nogueira R; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM Clin Exp Immunol; 2007 Sep; 149(3):440-4. PubMed ID: 17614975 [TBL] [Abstract][Full Text] [Related]
20. Combination of flow cytometry and qPCR to study the immune response of american cutaneous leishmaniasis patients. Brelaz-de-Castro MCA; de Almeida TM; de Almeida AF; de Assis Souza M; de Oliveira Mendes AP; Silva RFE; de Brito MEF; Pereira VRA Microb Pathog; 2018 Oct; 123():433-439. PubMed ID: 30076983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]